Received Mar 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | UNK | U7899AA | OT |
| HEP | HEP B (RECOMBIVAX HB) | MERCK & CO. INC. | UNK | X027728 | OT |
no adverse event; Medical assistant calling to report a patient was inadvertently administered both the RECOMBIVAX HB and VAXELIS Vaccines on the same day on 12/20/2024. No symptoms reported as of now, however caller states they have not followed up with the parents; This spontaneous report was received from a medical assistant concerning a 2-month-old male patient. The patient's pertinent medical history, past drug reactions or allergies, concurrent conditions and concomitant therapies were not provided. On 20-DEC-2024, the patient was inadvertently administered both the Hepatitis B Vaccine (Recombinant) (lot #X027728, expiration date: 16-Oct-2026) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (+) Inactivated Poliovirus (+) Haemophilus b Conjugate [Meningococcal Protein Conjugate] and Hepatitis B Vaccine (VAXELIS), Unknown (lot #U7899AA, expiration date: 31-Aug-2026). Both administered as prophylaxis (route, dose, anatomical site were not reported) (vaccine overdose). No symptoms reported as of now, however the reporter stated that they have not followed up with the parents to confirm. The patient's next appointment would be on 20-FEB-2025. No additional details were provided. The operator of device was healthcare professional.; Reporter's Comments: Keywords : BP